SCHEMBL2018257

SCHEMBL2018257

CCOC(=O)C(CC)S(C)(=O)=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.40
LMNA P02545 1/20 0.39
HSD17B10 Q99714 1/20 0.39
GAA P10253 2/20 0.37
ALOX15 P16050 1/20 0.37
MGAM O43451 1/20 0.37
SI P14410 1/20 0.37
MGAM2 Q2M2H8 1/20 0.37
SOAT1 P35610 1/20 0.37
PIN1 Q13526 1/20 0.36
TRPA1 O75762 1/20 0.34
CPB2 Q96IY4 1/20 0.34
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34
HPGD P15428 3/20 0.33
RECQL P46063 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31454832 1.00 ALDH1A1 (0.40) ALDH1A1LMNAHSD17B10GAAALOX15
SCHEMBL28947569 0.82 CA1 (0.41) GAAMGAMSIMGAM2CA12
Hydrochloric Acid SCHEMBL28316002 0.80 CA1 (0.39) GAAMGAMSIMGAM2CA12
SCHEMBL29553275 0.80 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10GAAALOX15
SCHEMBL29553630 0.80 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10GAAALOX15
SCHEMBL5014804 0.80 RECQL (0.42) ALDH1A1LMNAHSD17B10GAAALOX15
SCHEMBL12687306 0.79 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10GAAALOX15
SCHEMBL9567302 0.79 RECQL (0.43) ALDH1A1LMNAHSD17B10CPB2CA1
SCHEMBL18978399 0.79 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10GAAALOX15
SCHEMBL9650610 0.76 ALDH1A1 (0.43) ALDH1A1LMNAHSD17B10GAAALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106573924-B Isoxazoline hydroxamic acid derivs as LpxC inhibitor 诺华股份有限公司 2019-06-25 CN disclosed
CN-108368053-A Substituted benzazepine derivatives as antibacterial compounds 葛兰素史密斯克莱知识产权发展有限公司 2018-08-03 CN disclosed
CN-106573924-A Isoxazoline hydroxamic acid derivatives as LpxC inhibitors 诺华股份有限公司 2017-04-19 CN disclosed
US-9180123-B2 N-link hydroxamic acid derivatives useful as antibacterial agents PFIZER INC. (US) 2015-11-10 US disclosed
US-20150182513-A1 N-Link Hydroxamic Acid Derivatives Useful As Antibacterial Agents PFIZER INC. (US) 2015-07-02 US disclosed
US-9018384-B2 N-link hydroxamic acid derivatives useful as antibacterial agents PFIZER INC. (US) 2015-04-28 US disclosed
US-20140343031-A1 N-Link Hydroxamic Acid Derivatives Useful As Antibacterial Agents PFIZER INC. (US) 2014-11-20 US disclosed
EP-2512474-B1 N-LINKED HYDROXAMIC ACID DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS PFIZER (US) 2014-11-05 EP disclosed
US-8846933-B2 N-link hydroxamic acid derivatives useful as antibacterial agents PFIZER INC. (US) 2014-09-30 US disclosed
US-20140128363-A1 N-Link Hydroxamic Acid Derivatives Useful As Antibacterial Agents PFIZER (US) 2014-05-08 US disclosed
US-8664401-B2 N-linked hydroxamic acid derivatives useful as antibacterial agents PFIZER INC. (US) 2014-03-04 US disclosed
EP-2512474-A1 N-LINKED HYDROXAMIC ACID DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS Pfizer Inc. (US) 2012-10-24 EP disclosed
US-20120258948-A1 N-Linked Hydroxamic Acid Derivatives Useful As Antibacterial Agents PFIZER INC. 2012-10-11 US disclosed
WO-2011073845-A1 N-LINKED HYDROXAMIC ACID DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS PFIZER INC. (US) 2011-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150182513-A1 N-Link Hydroxamic Acid Derivatives Useful As Antibacterial Agents LPXN, NAAA, AGXT ALDH1A1 3989/4885LMNA 442/4885HSD17B10 915/4885
US-20120258948-A1 N-Linked Hydroxamic Acid Derivatives Useful As Antibacterial Agents LPXN, LCT, HAX1 ALDH1A1 2520/4885LMNA 269/4885HSD17B10 892/4885
US-20140128363-A1 N-Link Hydroxamic Acid Derivatives Useful As Antibacterial Agents LPXN, NAAA, AGXT ALDH1A1 3989/4885LMNA 442/4885HSD17B10 915/4885
US-20140343031-A1 N-Link Hydroxamic Acid Derivatives Useful As Antibacterial Agents LPXN, NAAA, AGXT ALDH1A1 3989/4885LMNA 442/4885HSD17B10 915/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.